Pages that link to "Q72637519"
Jump to navigation
Jump to search
The following pages link to [The solubility and bioequivalence of silymarin preparations] (Q72637519):
Displaying 11 items.
- Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability (Q33986021) (← links)
- The use of silymarin in the treatment of liver diseases (Q34104302) (← links)
- Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin (Q35781985) (← links)
- Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans (Q35792862) (← links)
- Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation (Q37164213) (← links)
- Effect of silymarin supplement on the pharmacokinetics of rosuvastatin (Q40018547) (← links)
- Pharmacokinetic evaluation of herbal remedies. Basic introduction, applicability, current status and regulatory needs (Q41508728) (← links)
- Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers (Q46120062) (← links)
- Biopharmaceutical characterisation of herbal medicinal products: are in vivo studies necessary? (Q73079094) (← links)
- Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity (Q84554863) (← links)
- Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review (Q89742070) (← links)